Corporate Compliance & Audit Readiness

Corporate Compliance and Audit Readiness in Pharma: Building a Culture of Inspection Preparedness

Corporate compliance refers to an organization-wide adherence to applicable laws, regulations, standards, and ethical practices. In pharmaceuticals, it spans across GMP, GCP, GLP, GDP, and other GxP requirements. It also…

Audit Failures and Repeat Findings? Corporate Compliance Solutions

The first indication of audit readiness issues often comes from symptoms observed either on the manufacturing floor or within laboratory environments. These signals can manifest in various forms, such as:Click…

Inspection readiness untested during corporate review – how to satisfy FDA/EMA expectations

Recognizing the symptoms or signals that indicate a gap in inspection readiness is a crucial first step in addressing potential deviations. These signals can manifest in various areas, including:Click to…

Global SOP harmonization gaps before regulatory inspection – enforcement risk and mitigation plan

Recognizing early signals of SOP harmonization gaps is essential for preemptive action. When inconsistencies arise, they often manifest in various forms:Click to read the full article.

Internal audit findings ignored during mock audit – CAPA program design

Identifying symptoms that signify internal audit findings have been overlooked is critical. Here, we focus on the most common signals:Click to read the full article.

Internal audit findings ignored during remediation – preventing repeat observations

Recognizing symptoms or signals indicative of ignored internal audit findings is the first step in initiating an investigation. Common signals may include:Click to read the full article.

Management review ineffective during mock audit – preventing repeat observations

Identifying the early warning signals of an ineffective management review is critical. Symptoms can manifest at various levels, including:Click to read the full article.

Management review ineffective during corporate review – evidence pack for inspectors

Identifying symptoms of ineffective management reviews is the first essential step in the investigation process. These signals might include:Click to read the full article.

Global SOP harmonization gaps during corporate review – CAPA program design

Identifying symptoms of harmonization gaps typically begins in two primary areas: the manufacturing floor and laboratory settings. Key signals may include inconsistencies in training documentation, discrepancies in SOP execution, and…

Global SOP harmonization gaps during remediation – preventing repeat observations

Identifying symptoms of SOP harmonization gaps is the first step in initiating an effective investigation. These signals can manifest in various forms, including but not limited to:Click to read the…

Compliance gaps not escalated during corporate review – evidence pack for inspectors

Addressing Compliance Gaps Not Escalated During Corporate Review: An Investigation Approach During corporate reviews, unaddressed compliance gaps can jeopardize regulatory standing and operational integrity. This article outlines an effective investigation…

Management review ineffective during corporate review – how to satisfy FDA/EMA expectations

Identifying symptoms or signals indicating ineffective management reviews is crucial for early detection and intervention. These symptoms can manifest in various forms:Click to read the full article.